chr16-88877025-C-A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_005187.6(CBFA2T3):​c.1913G>T​(p.Arg638Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000749 in 1,335,962 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R638C) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 7.5e-7 ( 0 hom. )

Consequence

CBFA2T3
NM_005187.6 missense

Scores

6
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.45

Publications

0 publications found
Variant links:
Genes affected
CBFA2T3 (HGNC:1537): (CBFA2/RUNX1 partner transcriptional co-repressor 3) This gene encodes a member of the myeloid translocation gene family which interact with DNA-bound transcription factors and recruit a range of corepressors to facilitate transcriptional repression. The t(16;21)(q24;q22) translocation is one of the less common karyotypic abnormalities in acute myeloid leukemia. The translocation produces a chimeric gene made up of the 5'-region of the runt-related transcription factor 1 gene fused to the 3'-region of this gene. This gene is also a putative breast tumor suppressor. Alternative splicing results in transcript variants. [provided by RefSeq, Nov 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.12087312).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CBFA2T3NM_005187.6 linkc.1913G>T p.Arg638Leu missense_variant Exon 12 of 12 ENST00000268679.9 NP_005178.4 O75081-1
CBFA2T3NM_175931.3 linkc.1655G>T p.Arg552Leu missense_variant Exon 11 of 11 NP_787127.1 O75081-2
CBFA2T3XM_005256323.6 linkc.1838G>T p.Arg613Leu missense_variant Exon 11 of 11 XP_005256380.1
CBFA2T3XM_047434826.1 linkc.*1252G>T 3_prime_UTR_variant Exon 11 of 11 XP_047290782.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CBFA2T3ENST00000268679.9 linkc.1913G>T p.Arg638Leu missense_variant Exon 12 of 12 1 NM_005187.6 ENSP00000268679.4 O75081-1
CBFA2T3ENST00000327483.9 linkc.1655G>T p.Arg552Leu missense_variant Exon 11 of 11 1 ENSP00000332122.5 O75081-2
CBFA2T3ENST00000563856.1 linkn.880G>T non_coding_transcript_exon_variant Exon 3 of 3 2
CBFA2T3ENST00000563920.1 linkn.1018G>T non_coding_transcript_exon_variant Exon 2 of 2 2

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
7.49e-7
AC:
1
AN:
1335962
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
654608
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
29032
American (AMR)
AF:
0.00
AC:
0
AN:
27304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22396
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34454
South Asian (SAS)
AF:
0.00
AC:
0
AN:
72696
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35798
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3974
European-Non Finnish (NFE)
AF:
9.48e-7
AC:
1
AN:
1054904
Other (OTH)
AF:
0.00
AC:
0
AN:
55404
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.625
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 29, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1913G>T (p.R638L) alteration is located in exon 12 (coding exon 12) of the CBFA2T3 gene. This alteration results from a G to T substitution at nucleotide position 1913, causing the arginine (R) at amino acid position 638 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.084
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.48
.;T
Eigen
Benign
-0.46
Eigen_PC
Benign
-0.47
FATHMM_MKL
Benign
0.37
N
LIST_S2
Benign
0.73
T;T
M_CAP
Uncertain
0.16
D
MetaRNN
Benign
0.12
T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
1.9
.;L
PhyloP100
1.5
PrimateAI
Uncertain
0.76
T
PROVEAN
Benign
-2.2
N;N
REVEL
Benign
0.060
Sift
Uncertain
0.0020
D;D
Sift4G
Uncertain
0.0050
D;D
Polyphen
0.081
B;B
Vest4
0.28
MutPred
0.25
.;Loss of methylation at R638 (P = 0.0443);
MVP
0.58
MPC
0.92
ClinPred
0.53
D
GERP RS
3.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.22
gMVP
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs562711336; hg19: chr16-88943433; API